Evidence map›Paper›PMID 42593953›Full record

ArticleAmerican journal on intellectual and developmental disabilities2026

Characterizing Populations Based on Proximity to a Fragile X Syndrome Specialty Clinic.

Hidayat Y Ogunsola, April D Summers, Maria G Gonzalez, Angela M Thompson-Paul, Marc Schweizer, Robert M Miller, Hilary Rosselot, Sarah C Tinker

Abstract read
In one paragraph

Article in American journal on intellectual and developmental disabilities, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hidayat Y OgunsolaCenters for Disease Control and Prevention, Atlanta, GA.
April D SummersCenters for Disease Control and Prevention, Atlanta, GA.
Maria G GonzalezCenters for Disease Control and Prevention, Atlanta, GA.
Angela M Thompson-PaulCenters for Disease Control and Prevention, Atlanta, GA.
Marc SchweizerCenters for Disease Control and Prevention, Atlanta, GA.
Robert M MillerNational Fragile X Foundation, Washington, DC.
Hilary RosselotNational Fragile X Foundation, Washington, DC.
Sarah C TinkerCenters for Disease Control and Prevention, Atlanta, GA.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Fragile X syndrome (FXS) is a rare condition that can require lifelong specialized care for optimal management. We describe census-based characteristics of general U.S. populations defined by proximity to FXS specialty clinics to better understand potential barriers to access. We used Geographic Information System software to estimate drive times from U.S. census tract centroids to FXS clinics. Of the contiguous U.S. population, 36.4% lives ≤1 hour from the closest FXS clinic in the same state; 32.4% live >1 to 4 hours, 7.3% live >4 hours, and 23.8% have no FXS clinic in their state. Individuals residing >1 hr from or in a state without an FXS clinic, compared to <1 hr, were more commonly non-Hispanic White, had household income below 150% poverty level, had one or more disabilities, and lived in a household without an internet subscription. Populations living ≤1 hr from an FXS clinic more commonly spoke limited English, lived in multiunit housing, and did not have a vehicle. These results can be used to identify areas of higher need for improving access to specialty care, inform efforts to reduce disparities related to access, and facilitate more optimal healthcare for people with FXS.

Indexed as

Ambulatory Care FacilitiesFragile X SyndromeHealth Services AccessibilityAdolescentChildFemaleHumansMalePovertyUnited StatesFragile X syndromehealthcare accessrare diseases

Identifiers

PMID42593953
PMCPMC13479729

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.